Top

Reactions Weekly

Published in:

01-01-2023 | Tyrosine Kinase Inhibitors | Case report

Dasatinib/imatinib

Cytopenia and treatment failure: case report

Published in: Reactions Weekly | Issue 1/2023

Excerpt

Author Information

An event is serious (based on the ICH definition) when the patient outcome is&colon;

* death
* life-threatening
* hospitalisation
* disability
* congenital anomaly
* other medically important event

…

Country of occurrence, reporter country and primary source country not stated. Author's communication details not available.

Keshan A, et al. A Rollercoaster of Challenges: From Diagnosis to Treatment in a Unique Case of CML in Blast Crisis. Indian Journal of Hematology and Blood Transfusion 38 (Suppl. 1): S33, Nov 2022. Available from: URL: http://doi.org/10.1007/s12288-022-01605-2 [abstract]

Title: Dasatinib/imatinib
Cytopenia and treatment failure: case report
Publication date: 01-01-2023
Publisher: Springer International Publishing
Keywords: Tyrosine Kinase Inhibitors
Tyrosine Kinase Inhibitors
Dasatinib
Imatinib
Chronic Myeloid Leukemia
Published in: Reactions Weekly / Issue 1/2023
Print ISSN: 0114-9954
Electronic ISSN: 1179-2051
DOI: https://doi.org/10.1007/s40278-023-31577-6

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Dasatinib/imatinib

Cytopenia and treatment failure: case report

Excerpt

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 1/2023

Minocycline/steroids

Fentanyl/hydromorphone/methadone

Multiple drugs

Betamethasone dipropionate/calcipotriol/lithium

Buprenorphine

Afatinib/osimertinib